For the quarter ending 2026-03-31, VNDA made $51,718K in revenue. -$48,567K in net income. Net profit margin of -93.91%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenues | 51,718 | 57,216 | 56,258 | 52,590 |
| Cost of goods sold excluding amortization | 3,159 | 3,833 | 2,954 | 2,736 |
| Research and development | 28,435 | 29,006 | 22,563 | 21,990 |
| Selling, general and administrative | 68,361 | 62,978 | 60,273 | 64,616 |
| Intangible asset amortization | 1,987 | 1,752 | 1,752 | 1,751 |
| Total operating expenses | 101,942 | 97,569 | 87,542 | 91,093 |
| Loss from operations | -50,224 | -40,353 | -31,284 | -38,503 |
| Other income, net | 1,800 | 2,351 | 2,894 | 3,616 |
| Loss before income taxes | -48,424 | -38,002 | -28,390 | -34,887 |
| Provision (benefit) for income taxes | 143 | 103,185 | -5,804 | -7,680 |
| Net loss | -48,567 | -141,187 | -22,586 | -27,207 |
| Basic EPS | -0.82 | -2.389 | -0.38 | -0.46 |
| Diluted EPS | -0.82 | -2.389 | -0.38 | -0.46 |
| Basic Average Shares | 59,459,982 | 59,107,385 | 59,091,478 | 58,993,990 |
| Diluted Average Shares | 59,459,982 | 59,107,385 | 59,091,478 | 58,993,990 |
Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals Inc. (VNDA)